Brigham and Women's study finds women with higher carotenoid levels have reduced risk of breast cancer
Women with higher circulating carotenoid levels are at a reduced risk of breast cancer, according to a Brigham & Women's Hospital and Harvard Medical School study published December 6 in the Journal of the National Cancer Institute. Carotenoids, which are micronutrients found in fruits and vegetables, have been found to have anticarcinogenic properties. Previous experimental studies have shown that carotenoids inhibit the tumor progression and reduce proliferation of estrogen receptor–positive (ER+) and estrogen receptor–negative (ER-) breast cancers. Brigham & Women's is a component of the Dana-Farber Cancer Institute.
Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.